ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 100 filers reported holding ADMA BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,022,332 | -13.4% | 5,034,171 | -10.7% | 0.06% | -22.2% |
| Q2 2023 | $20,811,489 | -5.7% | 5,639,970 | -15.4% | 0.07% | -7.7% |
| Q1 2023 | $22,061,220 | +240244.5% | 6,665,021 | +181.7% | 0.08% | +136.4% |
| Q4 2022 | $9,179 | -99.6% | 2,365,720 | +121.6% | 0.03% | +230.0% |
| Q3 2022 | $2,595,000 | +20.4% | 1,067,747 | -2.0% | 0.01% | +25.0% |
| Q2 2022 | $2,156,000 | +134.1% | 1,089,107 | +116.4% | 0.01% | +166.7% |
| Q1 2022 | $921,000 | +397.8% | 503,400 | +283.0% | 0.00% | +200.0% |
| Q4 2021 | $185,000 | +101.1% | 131,444 | +61.2% | 0.00% | – |
| Q3 2021 | $92,000 | -8.0% | 81,545 | +30.7% | 0.00% | – |
| Q2 2021 | $100,000 | -26.5% | 62,376 | -19.2% | 0.00% | -100.0% |
| Q1 2021 | $136,000 | -88.8% | 77,187 | -81.3% | 0.00% | -87.5% |
| Q2 2020 | $1,209,000 | – | 412,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |